Alpha 2.0
Login Register
» Articles » PMID: 19541892

Factors Associated with Anaemia in HIV-infected Individuals in Southern India

Overview
Journal Int J STD AIDS
Specialty Infectious Diseases
Date 2009 Jun 23
PMID 19541892
Citations 28
Authors
R Subbaraman
B Devaleenal
P Selvamuthu
T Yepthomi
S S Solomon
K H Mayer
N Kumarasamy
Affiliations
Soon will be listed here.
Abstract

Anaemia accelerates disease progression and increases mortality among HIV-infected individuals. Few studies have characterized this problem in developing countries. Haemoglobin values of adults presenting to an HIV tertiary care center in India between 1996 and 2007 were collected (n = 6996). Multivariate logistic regression analysis was performed to examine associations among anaemia, HIV progression and co-morbidities. Overall, anaemia prevalence was 41%. Twenty percent of patients with CD4 counts >500 cells/microL were anaemic, compared with 64% of those with CD4 counts <100 cells/microL (P < 0.001). In multivariate analysis, CD4 count <100 cells/microL (odds ratio [OR]:5.0, confidence interval [CI]:4.0-6.3), underweight body mass index (OR:4.8, CI:3.6-6.5), female gender (OR:3.1, CI:2.8-3.6) and tuberculosis (TB) (OR:1.6, CI:1.4-1.8) were significantly associated with anaemia. In this setting, management of anaemia should focus on antiretroviral therapy, nutritional supplementation and TB control. The high anaemia prevalence among patients meeting criteria for antiretroviral therapy highlights the need for increased access to non-zidovudine nucleoside reverse transcriptase inhibitors in developing countries.

Citing Articles

Clinical Implications of Anemia Among Eastern Sudanese HIV Survivors.

Bashir B Cureus. 2024; 16(5):e60766.

PMID: 38903363 PMC: 11187999. DOI: 10.7759/cureus.60766.

Prediction of the risk of cytopenia in hospitalized HIV/AIDS patients using machine learning methods based on electronic medical records.

Huang L, Xie B, Zhang K, Xu Y, Su L, Lv Y Front Public Health. 2023; 11:1184831.

PMID: 37575113 PMC: 10416630. DOI: 10.3389/fpubh.2023.1184831.

Anemia and opportunistic infections in hospitalized people living with HIV: a retrospective study.

Xie B, Huang W, Hu Y, Dou Y, Xie L, Zhang Y BMC Infect Dis. 2022; 22(1):912.

PMID: 36474196 PMC: 9727975. DOI: 10.1186/s12879-022-07910-5.

Prevalence of anaemia and the associated factors among hospitalised people living with HIV receiving antiretroviral therapy in Southwest China: a cross-sectional study.

Cao G, Long H, Liang Y, Liu J, Xie X, Fu Y BMJ Open. 2022; 12(7):e059316.

PMID: 35851012 PMC: 9297216. DOI: 10.1136/bmjopen-2021-059316.

Prevalence and Predictors of Cytopenias in HIV-Infected Adults at Initiation of Antiretroviral Therapy in Mehal Meda Hospital, Central Ethiopia.

Fiseha T, Ebrahim H J Blood Med. 2022; 13:201-211.

PMID: 35502291 PMC: 9056021. DOI: 10.2147/JBM.S355966.

References
1.
Moore R, Forney D . Anemia in HIV-infected patients receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002; 29(1):54-7. DOI: 10.1097/00042560-200201010-00007. View
2.
Semba R, Martin B, Kempen J, Thorne J, Wu A . The impact of anemia on energy and physical functioning in individuals with AIDS. Arch Intern Med. 2005; 165(19):2229-36. DOI: 10.1001/archinte.165.19.2229. View
3.
Semba R, Shah N, Klein R, Mayer K, Schuman P, Vlahov D . Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus-infected and -uninfected women. Clin Infect Dis. 2001; 34(2):260-6. DOI: 10.1086/338151. View
4.
OBrien M, Kupka R, Msamanga G, Saathoff E, Hunter D, Fawzi W . Anemia is an independent predictor of mortality and immunologic progression of disease among women with HIV in Tanzania. J Acquir Immune Defic Syndr. 2005; 40(2):219-25. DOI: 10.1097/01.qai.0000166374.16222.a2. View
5.
Kumarasamy N, Solomon S, Flanigan T, Hemalatha R, Thyagarajan S, Mayer K . Natural history of human immunodeficiency virus disease in southern India. Clin Infect Dis. 2002; 36(1):79-85. DOI: 10.1086/344756. View